Publicacions en què col·labora amb Fernando Vidal Vanaclocha (9)

2012

  1. Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis

    Gut, Vol. 61, Núm. 10, pp. 1465-1472

2011

  1. Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18

    Journal of Translational Medicine, Vol. 9

2003

  1. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis

    Hepatology, Vol. 37, Núm. 3, pp. 674-685

  2. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.

    Methods in molecular medicine, Vol. 85, pp. 79-86

2002

  1. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium

    Hepatology, Vol. 35, Núm. 5, pp. 1104-1116

1998

  1. Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver

    Journal of Cellular Physiology, Vol. 174, Núm. 3, pp. 322-330

1997

  1. Characterization of a new human liver myofibroblast cell line: Transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor β1

    Laboratory Investigation, Vol. 77, Núm. 1, pp. 63-70

  2. Interleukin 1-dependent and -independent mouse melanoma metastases

    Journal of the National Cancer Institute, Vol. 89, Núm. 9, pp. 645-651

  3. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis

    Hepatology, Vol. 26, Núm. 3, pp. 634-642